BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26151694)

  • 21. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
    Tsuda T; Tada H; Tanaka Y; Nishida N; Yoshida T; Sawada T; Sakata K; Hayashi K; Kawashiri MA; Oyama T; Sasaki M; Kurose N; Yamagishi M
    J Med Case Rep; 2018 Apr; 12(1):95. PubMed ID: 29653592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone liver toxicity about two cases and review of literature].
    Iba-Ba J; Tilea M; Balligand JL; Lefebvre C
    Rev Med Interne; 2004 May; 25(5):386-9. PubMed ID: 15110957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granular cells as a marker of early amiodarone hepatotoxicity.
    Jain D; Bowlus CL; Anderson JM; Robert ME
    J Clin Gastroenterol; 2000 Oct; 31(3):241-3. PubMed ID: 11034006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature.
    Rätz Bravo AE; Drewe J; Schlienger RG; Krähenbühl S; Pargger H; Ummenhofer W
    Crit Care Med; 2005 Jan; 33(1):128-34; discussion 245-6. PubMed ID: 15644659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal amiodarone-induced hepatotoxicity: a case report and literature review.
    Chan AL; Hsieh HJ; Hsieh YA; Lin SJ
    Int J Clin Pharmacol Ther; 2008 Feb; 46(2):96-101. PubMed ID: 18218290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal hepatotoxicity following oral administration of amiodarone.
    Richer M; Robert S
    Ann Pharmacother; 1995 Jun; 29(6):582-6. PubMed ID: 7663029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?
    Rhodes A; Eastwood JB; Smith SA
    Gut; 1993 Apr; 34(4):565-6. PubMed ID: 8491409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute hepatitis following amiodarone administration].
    Tagliamonte E; Cice G; Ducceschi V; Mayer MS; Iacono A
    Minerva Cardioangiol; 1997 Sep; 45(9):451-6. PubMed ID: 9446068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone.
    Hashmi A; Keswani NR; Kim S; Graham DY
    South Med J; 2016 Feb; 109(2):83-6. PubMed ID: 26840961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical applications and acute hepatotoxicity of intravenous amiodarone.
    Huang X; Yang Y; Zhu J; Gao X; Wang G; Tan H; Liang Y; Li J
    J Int Med Res; 2009; 37(6):1928-36. PubMed ID: 20146893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
    Raja K; Thung SN; Fiel MI; Chang C
    Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amiodarone-induced liver dysfunctions].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Jul; 135(27):1372-4. PubMed ID: 20589584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.
    Ye JH; Ho YF; On AW; Chen WW; Huang YM; Huang WI; Tang YW
    Int J Clin Pharm; 2018 Aug; 40(4):911-920. PubMed ID: 30051228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone-induced severe hepatitis mediated by immunological mechanisms.
    Breuer HW; Bossek W; Haferland C; Schmidt M; Neumann H; Gruszka J
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):350-2. PubMed ID: 9660045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early hepatitis during intravenous amiodarone administration.
    Morelli S; Guido V; De Marzio P; Aguglia F; Balsano F
    Cardiology; 1991; 78(3):291-4. PubMed ID: 1868505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report.
    Alanli R; Kucukay MB; Ozdemir O
    Indian J Pharmacol; 2021; 53(1):60-62. PubMed ID: 33976000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic dysfunction and neurotoxicity in a patient receiving long-term low-dose amiodarone therapy.
    Arkun A; Van Deusen SK; Grau T; Birkhahn RH
    J Emerg Med; 2010 Apr; 38(3):337-9. PubMed ID: 18757154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How toxic is amiodarone to the liver?
    Pollak PT
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):11-3. PubMed ID: 20361068
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pancreatitis and inappropriate ADH secretion syndrome associated with amiodarone].
    Muñoz Ruiz AI; Calvo Elipe A; Guerrero Vega E; Gorgojo Martínez JJ; Vera López E; Gilsanz Fernández C
    An Med Interna; 1996 Mar; 13(3):125-6. PubMed ID: 8679841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute toxic hepatitis after amiodarone intravenous loading.
    Rizzioli E; Incasa E; Gamberini S; Savelli S; Zangirolami A; Tampieri M; Manfredini R
    Am J Emerg Med; 2007 Nov; 25(9):1082.e1-4. PubMed ID: 18022508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.